1 May 2025

Last updated: Tuesday 29 April 2025

Research Directory

FDA lays out regulatory science strategy

How induced pluripotent stem cells are becoming a tool for personalised medicine

Cellzome secures a lead in drug discovery

Innate Pharma's anti-cancer platform attracts BMS investment

Update on Personalised Medicine

Is the diagnostic part of personalised medicine underpaid?

EMA gives its first opinion on human use of biomarkers

Vaccinating against the tumour vasculature

Virtual drug development at Eli Lilly

Managing Innovation at AstraZeneca